Investors in Pacira BioSciences, Inc. PCRX need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $2.5 Call had some of the highest …
Is the Options Market Predicting a Spike in Pacira BioSciences Stock?
view original post